Esken Limited
ESKNF · OTC
8/31/2023 | 2/28/2023 | 8/31/2022 | 2/28/2022 | |
|---|---|---|---|---|
| Revenue | $5 | $62 | $58 | $52 |
| % Growth | -92.6% | 6.4% | 11.1% | – |
| Cost of Goods Sold | $7 | $70 | $65 | $38 |
| Gross Profit | -$2 | -$8 | -$7 | $14 |
| % Margin | -51% | -13% | -11.7% | 26.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $2 |
| SG&A Expenses | $0 | $0 | $0 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $5 | $2 | $1 | $56 |
| Operating Expenses | $5 | -$2 | -$1 | $57 |
| Operating Income | -$7 | -$6 | -$6 | -$4 |
| % Margin | -150.4% | -10.3% | -10.8% | -7.7% |
| Other Income/Exp. Net | -$24 | -$1 | -$2 | -$10 |
| Pre-Tax Income | -$31 | -$7 | -$9 | -$17 |
| Tax Expense | -$0 | $0 | -$3 | -$5 |
| Net Income | -$60 | -$17 | -$9 | -$12 |
| % Margin | -1,318.2% | -26.9% | -14.8% | -23.6% |
| EPS | -0.03 | -0.016 | -0.009 | -0.015 |
| % Growth | -82.2% | -91.8% | 43% | – |
| EPS Diluted | -0.03 | -0.016 | -0.008 | -0.015 |
| Weighted Avg Shares Out | 1,018 | 1,021 | 1,017 | 827 |
| Weighted Avg Shares Out Dil | 1,021 | 1,021 | 1,021 | 827 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $6 | $1 |
| Interest Expense | $45 | $13 | $0 | $11 |
| Depreciation & Amortization | $2 | $9 | $9 | $10 |
| EBITDA | -$2 | $6 | $4 | $3 |
| % Margin | -50.1% | 9.3% | 7.6% | 5.8% |